Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,793,957 | 2,393,607 | 2,212,304 | 2,093,669 | 1,992,523 |
| Cost of Goods | 1,773,519 | 1,573,042 | 1,427,596 | 1,324,696 | 1,364,130 |
| Gross Profit | 1,020,438 | 820,565 | 784,708 | 768,973 | 628,393 |
| Operating Expenses | 771,631 | 616,233 | 880,232 | 616,953 | 537,368 |
| Operating Income | 249,326 | 204,374 | -94,928 | 152,716 | 91,155 |
| Interest Expense | 258,595 | 210,629 | 158,377 | 136,325 | 145,998 |
| Other Income | -45,744 | -34,015 | 5,178 | 14,975 | 19,063 |
| Pre-tax Income | -55,013 | -40,270 | -248,127 | 31,366 | -35,780 |
| Income Tax | 18,863 | 8,452 | 6,662 | 11,196 | -104,358 |
| Net Income Continuous | -73,876 | -48,722 | -254,789 | 20,170 | 68,578 |
| Minority Interests | 43,010 | 35,271 | -124,803 | 9,546 | -22,481 |
| Net Income | $-116,886 | $-83,993 | $-129,986 | $10,624 | $91,059 |
| EPS Basic Total Ops | -0.38 | -0.48 | -0.86 | 0.07 | 0.62 |
| EPS Basic Continuous Ops | -0.24 | -0.28 | -1.69 | 0.14 | 0.47 |
| EPS Diluted Total Ops | -0.38 | -0.48 | -0.86 | 0.07 | 0.61 |
| EPS Diluted Continuous Ops | -0.24 | -0.28 | -1.69 | 0.13 | 0.46 |
| EPS Diluted Before Non-Recurring Items | 0.51 | 0.55 | 0.60 | 0.71 | 0.52 |
| EBITDA(a) | $514,614 | $445,322 | $153,842 | $395,325 | $335,220 |